FirstWord Pharma PLUS editors Simon King and Michael Flanagan discuss this week’s key industry news stories, including safety concerns for AstraZeneca’s COVID-19 vaccine in Europe, the FTC’s plans to scrutinise pharma M&A more closely, Eli Lilly’s latest Alzheimer’s disease data and a noteworthy collaboration between Gilead and Merck in HIV.